Chromatin condensation paralleled by DNA fragmentation is one of the most important nuclear events occurring during apoptosis. Histone modifications, and in particular phosphorylation, have been suggested to affect chromatin function and structure during both cell cycle and cell death. We report here that phosphate incorporation into all H1 subtypes decreased rapidly after induction of apoptosis, evidently causing a strong reduction in phosphorylated forms of main H1 histone subtypes. H1 dephosphorylation is accompanied by chromatin condensation preceding the onset of typical chromatin oligonucleosomal fragmentation, whereas H2A.X hyperphosphorylation is strongly correlated to apoptotic chromatin fragmentation. Using various kinase inhibitors we were able to exclude some of the possible kinases which can be involved directly or indirectly in phosphorylation of histone H2A.X. Neither DNA-dependent protein kinase, protein kinase A, protein kinase G, nor the kinases driven by the mitogenactivated protein kinase (MAP) pathway appear to be responsible for H2A.X phosphorylation. The protein kinase C activator phorbol 12-myristate 13-acetate (PMA), however, markedly reduced the induction of apoptosis in TNFa-treated cells with a simultaneous change in the phosphorylation pattern of histone H2A.X. Hyperphosphorylation of H2A.X in apoptotic cells depends indirectly on activation of caspases and nuclear scaffold proteases as shown in zVAD-(OMe)-fmkor zAPF-cmk-treated cells, whereas the dephosphorylation of H1 subtypes seems to be influenced solely by caspase inhibitors. Together, these results illustrate that H1 dephosphorylation and H2A.X hyperphosphorylation are necessary steps on the apoptotic pathway.
Introduction
Apoptosis is an active form of cellular suicide with many welldefined morphological and biochemical features. The process of apoptosis is initiated by external inducers or treatments including UV-or g-irradiation, heat shock, oxidative stress, viral infection, glucocorticoids, soluble or membrane-bound cytokines like TNF or Fas/Apo-1 (CD95) ligand and many others. The different pathways of these various agents then presumably converge to form an apoptotic pathway common to all cells. Whereas the early stages of apoptosis are biochemically well characterized, the biochemical basis for the nuclear events is still unclear. The morphological nuclear events of apoptosis are chromatin condensation, DNA fragmentation to domain-sized fragments (200 ± 300 kb and 30 ± 50 kb) and finally to nucleosomal-sized fragments (180 ± 200 bp).
1,2 An apoptosis-specific caspase-activated DNase termed CAD or DFF40 seems to be responsible for internucleosomal DNA cleavage 3, 4 and chromatin condensation as well as formation of apoptotic bodies. 5 It is, however, not fully understood whether apoptotic fragmentation of chromatin occurs randomly or whether specific modifications of chromatin-associated proteins determine preferential cleavage. Little is known about the mechanism or the biological function of chromatin condensation and internucleosomal DNA cleavage after apoptosis induction. The late stages of the apoptotic process typically involve cleavage of specific target proteins like lamin, 6 actin 7 or poly(ADP-ribose) polymerase. 8, 9 Several protein kinases like DNA-dependent protein kinase, 10 or protein kinase Cd 11 have been proposed as being involved in apoptosis. Phosphorylation and dephosphorylation of proteins are essential control elements in cell cycle progression and are also involved in structural changes in chromatin. Histone phosphorylation at specific sites, in particular, has been shown to be involved in structural changes in chromatin during the cell cycle. 12 The cdc 2/H1 kinase-dependent phosphorylation of H1 histones during the cell cycle is a dynamic process with a phosphorylation maximum during mitosis. 13 Whereas H2A histones are constantly phosphorylated, phosphorylation of H4 and H2B histones is negligible throughout the cell cycle. Histone H3 phosphorylation, in particular, appears to be essential for proper mitotic chromosome condensation and segregation, 14, 15 but was also shown to be involved in premature chromosome condensation. In apoptotic cells, however, with chromatin condensation as an essential nuclear event, histone H3 phosphorylation at mitosis-associated sites does not occur, although H2B phosphorylation at the specific serine 32 was associated with DNA fragmentation in mammalian apoptotic cells. 16 Since histones and their modified forms play a fundamental role in chromatin structure, the aim of this study was to investigate the phosphorylation events of histone proteins during apoptosis and to correlate them to morphological changes occurring in apoptotic cells. Using TNFa or agonistic anti-Fas antibody, NIH 3T3 cells are killed by both activating stimuli in a characteristically apoptotic fashion, causing phosphatidylserine externalization, and chromatin condensation. 17 Our results show that both TNFa-and CD95-mediated cell killing results in nearly the same change in the phosphorylation pattern of histone proteins. During induction of apoptosis but before initiation of nucleosomal fragmentation H1 histones became rapidly dephosphorylated, which was accompanied by condensation of chromatin. Parallel to nucleosomal chromatin fragmentation histone H2A.X became more highly phosphorylated with increasing amounts of mono-and diphosphorylated forms in the case of TNFa-or anti-Fas-induced apoptosis and mono-to triphosphorylated forms in cantharidin-treated cells.
Results
Morphological changes after apoptosis induction in NIH 3T3 cells Figure 1A shows the morphological features of nuclear chromatin in NIH 3T3 cells untreated ( Figure 1A , Control) or treated with TNFa in the presence of cycloheximide for 1 to 8 h ( Figure 1A ). Treatment with either cycloheximide, a potent protein synthesis inhibitor, or TNFa alone induces apoptosis after only 48 to 72 h. With the combination of TNFa and cycloheximide the induction of apoptosis in NIH 3T3 fibroblasts can be substantially accelerated. Nuclear fragmentation and condensation of the chromatin at the nuclear membrane are visible in fluorescence microscopy in some cells after 3 h of treatment. The number of cells with apoptotic features increased during the next 5 h of treatment, reaching about 80% of apoptotic cells after 8 h ( Figure 1A ). Figure 1B shows gel electrophoresis of DNA from cells after induction of apoptosis. One hour of TNFa treatment resulted in a small but clearly visible shift in high molecular weight DNA ( Figure 1B , lane 2), whereas after 2 h ( Figure 1B , lane 3) a DNA ladder started to become visible and was prominent after 8 h of TNFa treatment ( Figure 1B, lane 8) . Electron microscopy was used to demonstrate the morphological changes in NIH 3T3 cells after treatment with TNFa in greater detail (Figure 2 ). Control cells appeared normal, with typical distributions of nuclear heterochromatin, and with a smooth cell surface (Figure 2A ). One hour after incubation with TNFa, many cells exhibited pronounced blebbing. A thicker layer of condensed chromatin is present at most points of the nuclear membrane, sparing the nuclear pores (small arrow). (Figure 2B,H) . By 2 h the blebbing was accompanied by further condensation of the chromatin, which had begun to accumulate at the nuclear membrane ( Figure 2C ). Three to four hours after incubation with TNFa, condensation of chromatin at the nuclear membrane was conspicuous, and almost all the mitochondria were disrupted (Figures 2D,E) . By 6 h, many cells lacked integral cell membranes ( Figure 2F ), and the proportion of cells in this condition increased until the final electron microscopic observation at 8 h. The condensation of chromatin and its accumulation at the nuclear membrane is shown in greater detail in Figure 2G ± I.
Phosphorylation of histones in NIH 3T3 cells undergoing TNFa-induced apoptosis
To investigate the phosphorylation levels of histone variants after induction of apoptosis NIH 3T3 fibroblasts were labeled with [ 32 P]orthophosphate at various time points for 60 min and after histone extraction AUT ± PAGE in combination with autoradiography was used. It is obvious from the autoradiograph of Figure 3 that phosphate incorporation of nearly all histones continuously decreased substantially during the course of apoptosis, as compared to control cells (Figure 3 , autoradiograph). This effect is very pronounced in H1 histones (decrease to 10% from control) but is also expressed in all H3 variants (decrease to 25% from control) and H4 histones (decrease to 50% from control) and to a lesser extent is also visible in H2A.1 and H2A.2 histones. Interestingly, ubiquitinated H2A histones which showed a considerable (Figure 3, lanes 9 and 10) . In contrast to the dephosphorylation of most histones during the course of apoptosis, only two bands of histones showed a remarkable increase in phosphate incorporation (Figure 3 , autoradiograph, marked X), which is paralleled by the appearance of a new band barely visible at 2 h after apoptosis induction ( Figure 3 , Coomassie, lane 3) but clearly detectable after 6 h and 8 h (Figure 3 , Coomassie, lanes 7 and 8, arrow). The onset of phosphate incorporation at 2 h (threefold increase from control) with a maximum at 3 h (sixfold increase) and continuous incorporation for up to 8 h (twofold increase) (Figure 3 , autoradiograph, lanes 3 to 8) was paralleled by the onset of chromatin condensation ( Figure  2C , 2 h) and oligonucleosomal DNA laddering ( Figure 1B , 2 h). Based on the results obtained with AUT gels we supposed that these two bands are phosphorylated H2A variants. Using TNFa or cycloheximide alone for 8 h, no increase in phosphorylation of the H2A variants was observed ( Figure 3 , autoradiograph, lanes 9 and 10). Interestingly, a 72-h treatment with TNFa in the absence of cycloheximide causing apoptosis in 65% of the cells was paralleled by an increase in H2A.X phosphorylation and a decrease in H1 phosphorylation ( Figure 3 , lanes 11).
SDS ± PAGE and sequencing of phosphorylated H2A variants
To obtain more information about the identity of the bands shown in Figure 3 , the core histones of cells treated for 8 h with cycloheximide alone or with the combination of TNFa and cycloheximide were subjected to SDS gel analysis ( Figure 4A , lanes 1 and 2). In SDS gel H2A from cycloheximide-treated cells is the most prominent phosphorylated band in the core histone region ( Figure 4A , lane 1). When cells were treated with cycloheximide plus TNFa, a second phosphorylated band was visible in the region of histone H3 or H2B on SDS gel ( Figure 4A , lane 2). However, it was clearly visible on AUT gel ( Figure 3 ) that H2B was not and H3 was only weakly phosphorylated during the 60 min of labeling. Since it is known that H2A.X migrates almost coincidentally with H2B or H3 in SDS gels, we conclude that the proteins in question are in fact phosphorylated forms of H2A.X. To definitively clarify this presumption, sequence analysis of the two proteins was performed. The labeled proteins were separated by reversedphase HPLC ( Figure 4B ) and the resulting fractions designated 1 to 3 were analyzed on AUT ± PAGE and autoradiographed. The autoradiograph of these separated fractions is shown in Figure 4C . Fractions 2 and 3 correspond to the two unknown phosphorylated bands. Because of the fact that the N terminus of histone H2A.X is blocked, the primary structure in that region was impossible to determine. We therefore digested the two fractions with endopeptidase GluC and separated the resulting peptides using reversedphase HPLC (data not shown). Digestion of H2A.X with endopeptidase GluC, which cleaves at glutamic acid residues under the conditions applied, would be expected to yield a C-terminal fragment 49 residues long. In fact, we did detect such a C-terminal fragment in the two fractions, which was found to be radiolabeled. This C-terminal fragment was microsequenced and the first eight residues determined (bold letters) as 89DEELNKLLGGVTIA104 matching histone H2A.X. The specific activity of the upper phosphorylated band is twice as high as that of the lower phosphorylated H2A.X band, indicating that double the amount of phosphate was incorporated into each protein molecule in the upper band. Therefore, our experimental results indicate that the two labeled bands correspond to mono-and diphosphorylated histone H2A.X.
H1 subtype dephosphorylation pattern
In AUT ± PAGE it was not possible to resolve H1 subtypes or to show single phosphorylated forms of H1 histones. Therefore, because H1 dephosphorylation is one of the most obvious events during the course of apoptosis (see Figure 3 ), we used reversed-phase HPLC and AUT ± PAGE to prove whether a decrease in phosphate incorporation also leads to a decline in phosphorylated forms of the various H1 subtypes. Phosphate incorporation decreased quickly ( Figure 5 , autoradiograph, lane 2) during the early phase (1 h) of apoptosis to 50% from control (0 h). This extensive decline continued during the subsequent hours of treatment to 10% from control ( Figure 5 , autoradiograph, lanes 4 and 5), apparently causing the disappearance of phosphorylated forms of H1 subtypes ( Figure 5 , Coomassie, lanes 7 to 11). The main H1 subtypes of NIH 3T3 cells showed a considerable amount of phosphorylated forms in untreated cells: 55% of H1b, 45% H1c, 35% of H1d and H1e were phosphorylated forms in control cells, whereas 1 h after treatment the phosphorylated forms decreased of about 10%, 8 h after treatment only about 12% of H1b, 10% of H1c and 5% of H1d and H1e were phosphorylated. It must be emphasized, however, that treatment of cells with cycloheximide alone also tended to give nearly the same low level of phosphorylated H1 histones (see Figure 3 , lanes 10 and Figure 5 , lanes 6 and 12) without inducing typical apoptotic nuclear morphology during this time. Therefore, H1 dephosphorylation per se is clearly not able to induce chromatin condensation or DNA fragmentation but could be a prerequisite for chromatin alteration.
Phosphorylation changes in histone proteins after apoptosis induction with anti-Fas antibody or phosphatase inhibitor cantharidin and ubiquitinated H2A histones only minimal phosphate incorporation occurred, whereas H2A.X was hyperphosphorylated. However, the hyperphosphorylation of H2A.X was more pronounced, because in addition to diphosphorylated H2A.X forms even triphosphorylated ones appeared ( Figure 7 , lanes 4 and 9, arrows 2 and 3). Furthermore, H3.2 and H3.3 histones were hyperphosphorylated as compared to those of mitotic cells, and also H2A.1 and H2A.2 showed an increase in phosphate incorporation and the appearance of a second phosphorylated form. It must be mentioned, however, that the triphosphorylated form of H2A.X and the diphosphorylated form of H2A.1 and H2A.2 can also be explained as a cantharidine-induced hyperacetylation of mono-or diphosphorylated H2A forms, also producing the observed banding pattern. The addition of cycloheximide to cantharidin-treated cells diminished the hyperphosphorylation of H3.2 and H3.3 histone variants but not that of histone H2A.X (Figure 7 , lanes 5 and 10, arrows 2 and 3) and further decreased H1 phosphorylation. Microscopic examination of cantharidin plus cycloheximide-treated cells showed 80% of cells to have a typical apoptotic nuclear morphology; many of them showed chromatin fibers arranged in loops outside the nuclear membrane ( Figure 6A, panel 3, arrows) . DNA laddering was not more pronounced as compared to only cantharidin treatment ( Figure 6B, lane 3) . The Coomassie-stained AUT gels clearly demonstrated the mass amounts of the different phosphorylated forms of H2A.X. Whereas in control cells about 60% of unphosphorylated and 40% of monophosphorylated forms are present, TNFa-and Fas-treated cells show about 40% of unphosphorylated, 50% of monophosphorylated and 10% of diphosphorylated forms ( Figure  7 , Coomassie, lanes 6 to 8). In cantharidin-treated cells about 33% of unphosphorylated, 37% of monophosphorylated, 20% of diphosphorylated and 10% of triphosphorylated forms can be detected (Figure 7 , Coomassie, lanes 9 and 10).
Effect of kinase inhibitors or activators on TNFa-or Fas-induced apoptosis and histone H2A.X phosphorylation To obtain information concerning the kinase(s) responsible for apoptotic H2A.X phosphorylation in vivo, we induced apoptosis in the presence of specific kinase inhibitors or (Table 1) . Neither in TNFa-nor in Fas-treated cells did the simultaneous addition of PKC inhibitor staurosporine, tyrosin PK inhibitor genistein, PKA inhibitor H89, which at higher doses also inhibits PKG and PKC, or DNA PK inhibitor Wortmannin result in a marked specific suppression of the apoptosis inducer effects concerning cell morphology or H2A.X phosphorylation (Table 1) . Whereas the MEK (MAP) kinase inhibitor PD98059 was not able to inhibit apoptosis, the MAP kinase activator and inhibitor of phosphatases 1 and 2A calyculin A induced by itself an apoptosis-like state comparable to that achieved with okadaic acid 20, 21 or cantharidin. The PARP inhibitor 3-aminobenzamide, significantly delayed the TNFa induction of apoptosis but could not inhibit apoptosis or phosphorylation of H2A.X, whereas the protein kinase C activator PMA inhibited nearly completely induction of apoptosis and markedly reduced hyperphosphorylation of H2A.X but not dephosphorylation of H1 histones. In Fasinduced apoptosis none of the used kinase inhibitors or activators including PMA had an apoptosis-inhibiting effect or was able to prevent H2A.X hyperphosphorylation ( Table 1) or H1 dephosphorylation.
Effect of protease inhibitors on histone H2A.X phosphorylation of TNFa-or anti-Fas antibody-induced apoptosis
If H2A.X phosphorylation were directly correlated to apoptotic events, apoptosis inhibitors should be able to inhibit both TNFaand Fas-induced apoptosis as well as the apoptosiscorrelated hyperphosphorylation of histone H2A.X. The serine protease inhibitor TPCK ( Figure 8A , lanes 5 and 12, and Figure 8B , lanes 5 and 10) had only a weak effect on apoptosis and H2A.X phosphorylation, whereas the caspase-1 inhibitor Ac-YVAD-cmk ( Figure 8A , lanes 2 and 9, and Figure 8B , lanes 2 and 7) inhibited TNFa-but not anti-Fas antibody-induced apoptosis or H2A.X phosphorylation. The caspase-3 and caspase-7 inhibitor zDEVD-cmk was not able to inhibit apoptosis in TNFa-treated cells, and the phosphorylation pattern resembles that of apoptotic cells without caspase inhibtor ( Figure 8A, lanes 6 and 13) . The caspase inhibitor zVAD-(OMe)-fmk, which inhibits apoptosis at an early stage 22 ( Figure 8A , lanes 3 and 10, and Figure 8B , lanes 3 and 8) and the nuclear scaffold proteinase inhibitor zAPF-cmk The number of apoptotic Hoechst 33258-stained cells with chromatin condensation and fragmentation was counted under a¯uorescence microscope. Figure 8B , lanes 4 and 9), however, nearly totally inhibited both apoptosis and H2A.X hyperphosphorylation. Moreover, dephosphorylation of histone H1 and ubiquitinated H2A was inhibited by Ac-YVADcmk and zVAD-(OMe)-fmk treatment in TNFa-induced apoptosis ( Figure 8A, lanes 2, 3, 9 and 10 ) and by zVAD-(OMe)-cmk in anti-Fas antibody-treated cells ( Figure 8B , lanes 3 and 8) but not by nuclear scaffold proteinase inhibitor zAPF-cmk. Therefore, histone H2A.X phosphorylation seems to be a downstream consequence of caspase(s) and nuclear scaffold proteinase(s), whereas the putative protein phosphatases or protein kinase inhibitors responsible for the dephosphorylation of H1 histones after apoptosis induction may be activated by a mechanism which acts downstream from the caspase-dependent activation of apoptosis at or near the apex of the apoptotic cascade but upstream from the nuclear scaffold proteinase.
Discussion
The aim of the study was to correlate the morphological changes occurring during development of apoptosis in NIH 3T3 cells to the major changes in phosphorylation status in histone proteins. Our report documents that phosphate incorporation of most histones, especially of all subtypes of H1 histones, decreased very rapidly after apoptosis induction with TNFa or anti-Fas antibody in the presence of cycloheximide. In the case of H1 histones we demonstrated that reduced phosphate incorporation evidently caused a strong reduction of phosphorylated forms of the main H1 histone subtypes in NIH 3T3 cells. Although phosphate incorporation in both H3 and H4 histones decreased after TNFa-or anti-Fas antibody-induced apoptosis, we were not able to detect a reduction of phosphorylated forms in AUT ± PAGE. Furthermore, we also showed that phosphate incorporation and phosphorylated forms of ubiquitinated H2A histones decreased, which is consistent with the results of other laboratories. 23 During the course of apoptosis induced by TNFa or anti-Fas antibody, nearly no alteration of phosphorylated forms of H2A.1 or H2A.2 was detectable, whereas H2A.X became more highly phosphorylated with increasing amounts of diphosphorylated forms. In cantharidin-treated apoptotic cells H2A.X showed mono-, di-and even triphosphorylated forms, and H2A.1 and H2A.2 also became diphosphorylated.
Since the most pronounced changes in phosphate incorporation and mass pattern of phosphorylated forms apply to the H1 subtypes and histone H2A.X, and since these changes were found in apoptosis caused by all inducers we used, these histones were thought to most probably play a role in altering nuclear morphology.
Histone H2A.X belongs to the H2A subfamily, comprising about 10% of the H2A complement in NIH 3T3 cells, but shows differences as compared to H2A.1 and H2A.2. While the first 119 amino residues of the major histone H2A (H2A.1 and H2A.2) and H2A.X are homologous (96%), each histone has a unique carboxyl-terminal sequence. 24 Mouse H2A.X has an additional 13 amino acids at the carboxy terminus with the motif SQASQEY-(end) as compared to the other H2A histones. 25, 26 The phosphorylation sites found by us were located on the C-terminal fragment (data not shown), which occurs after digestion with endopeptidase GluC. This part is on the exterior of the nucleosome and should be easily accessible to kinases. 27 Phosphorylated H2A.X has been suggested to play important roles in generation-spaced (180 bp) nucleosomal array. 28, 29 Recently it was demonstrated 27,30 that on serine 139 H2A.X becomes phosphorylated rapidly and extensively after exposure of mammalian cell lines and mice to ionizing radiation, which leads to the formation of DNA double-stranded breaks. In a very recently published paper H2A.X phosphorylation was suggested to be closely linked to apoptotic DNA fragmentation as a DNA damage response prior to DNA repair. 31 Also in our present study we were able to demonstrate that during the course of apoptosis of NIH 3T3 cells the rise in phosphate incorporation into H2A.X and the increase in the diphosphorylated H2A.X form were obviously paralleled by the occurrence of internucleosomal DNA fragmentation (see Figures 1 and 3) . Also, cantharidin-induced apoptosis prompted DNA fragmentation comparable to that induced by TNFa or anti-Fas antibody treatment. Histone H2A.X, however, was phosphorylated to a greater extent (mainly di-and triphosphorylated forms). In addition to a serine at position 1, where monophosphorylation occurs, mouse H2A.X contains two further serines at position 136 and 139. 27 The triphosphorylated form of H2A.X might be explained by these serines as the preferred substrates for the kinase. The fact that cantharidin treatment beside chromatin fragmentation and condensation also induced partial release of chromatin fibers was interpreted as histone hyperphosphorylation-induced decondensation of parts of the chromatin. It must be mentioned, however, that H2A.1, H2A.2 and H3 histones were also hyperphosphorylated in cantharidin-treated cells and might be responsible for this effect. Whether these findings are due to hyperphosphorylation or other factors like lamin or nuclear matrix degradation remains to be determined.
The decrease in phosphate incorporation and dephosphorylation of H1 histones occurred very rapidly during all treatments used in this study to induce apoptosis. One hour after commencing apoptosis induction with TNFa the amount of phosphorylated H1 histones was obviously diminished (see Figure 5) . At this time a slight chromatin condensation at or near the nuclear membrane was also detectable in the electron micrograph (see Figures 2B and  H) and only a shift in high molecular weight DNA but not in nuclear scaffold proteinase inhibitor zAPF-cmk (50 mM); lanes 5 and 12: serine proteinase inhibitor TPCK (50 mM); lanes 6 and 13: caspase-3 and caspase-7 inhibitor zDEVD-cmk (200 mM); lanes 7 and 14: DNA-PK inhibitor Wortmannin (150 mM). (B) Autoradiograph and corresponding Coomassie-stained gel of histones from cells treated 16 h with anti-Fas antibody plus cycloheximide in the presence of the following inhibitors: lanes 1 and 6: without inhibitor; lanes 2 and 7: AC-YVAD-cmk (100 mM); lanes 3 and 8: zVAD-(OMe)-fmk (100 mM); lanes 4 and 9: zAPF-cmk (50 mM); lanes 5 and 10: TPCK (50 mM) oligonucleosomal DNA was detected (see Figure 1B) . H1 dephosphorylation was not inhibited by the PP1 and PP2A inhibitor calyculin A (data not shown). Moreover, the protein phosphatase inhibitor cantharidin by itself induced apoptosis, which is correlated to H1 dephosphorylation (see Figure 7, lanes 4 and 9) . Therefore, a phosphatase other than PP1 or PP2A in combination with the inhibition of the putative H1 protein kinase of the CDK family must be responsible for the rapid dephosphorylation of H1 histones. The apoptosis-inducing ability of TNFa or anti-Fas antibody in the absence of cycloheximide was much slower (48 h to 72 h) than in the presence of cycloheximide (8 h to 16 h). A 72-h treatment with TNFa in the absence of cycloheximide causing apoptosis in 65% of the cells was clearly paralleled by an increase in H2A.X phosphorylation and a decrease in H1 phosphorylation. However, cycloheximide alone was not able to induce apoptosis during 16 h of treatment but also prompted H1 histone dephosphorylation (see Figures 3 and  5) . Therefore, it can be concluded that, as expected, H1 dephosphorylation by itself is not able to induce apoptotic chromatin alterations, because rapid dephosphorylation of H1 histones also occurred during cell cycle after mitosis. Since H1 dephosphorylation preceded oligonucleosomal DNA fragmentation and paralleled chromatin condensation, we can speculate that chromatin alterations are accelerated and that H1 dephosphorylation makes DNA more accessible to DNase attack.
Our results exclude some of the kinases which could be responsible for phosphorylation of H2A.X. H2A.X is discussed as a substrate for phosphorylation by DNA-PK in vitro. 32 We used the Pl3-K inhibitor Wortmannin in a concentration so high that it also works as a DNA-PK inhibitor. 33 Apoptotic NIH 3T3 cells, however, did not exhibit a noticeable deficit of highly phosphorylated H2A.X (see Figure 8 , lanes 7 and 14), which prompted us to conclude that in the cell system used H2A.X is not the in vivo substrate of DNA-PK; this is in agreement with examinations of various DNA-PK-deficient mouse and hamster cell systems. 27 H2A.X may be involved in recognizing and repairing DNA strand breaks, but the phosphorylation of H2A.X seems to result from a DNA double-stranded break repair system that does not utilize DNA-PK.
The one or more kinases responsible for phosphorylation of H2A.X were influenced neither directly nor indirectly by protein kinase A 34 or G inhibitors, the tyrosine protein kinase inhibitor 35 or the MEK (MAP) kinase inhibitor used. Although the protein kinase C inhibitor staurosporine is described as inducing chromatin decondensation, 36 it was not able to inhibit chromatin condensation or fragmentation. Several reports show that the specific PARP inhibitor 3-aminobenzamide is able to inhibit cell death and apoptosis. 37 However, the ongoing apoptosis in NIH 3T3 cells after TNFa induction was only delayed and not inhibited. In this report we show that the phorbol ester PMA, a PKC activator, was able to inhibit TNFa-induced apoptosis together with phosphorylation of H2A.X, but only slightly influenced H1 dephosphorylation. It is known, however, that PKC activators inhibit receptor-mediated apoptosis 38 at a level upstream from caspase activation. Therefore the observed inhibition of H2A.X phosphorylation seems not to be directly linked to activation of PKC but could be a result of PKC-mediated inhibition of caspase activation. Activation of proteases and degradation of both the nuclear lamina and components of the intranuclear protein matrix enable aggregation of chromatin into apoptotic spherical bodies. 39 Furthermore, it is known that inhibition of lamin or nuclear scaffold degradation prevents nuclei from acquiring complete apoptotic features. 40, 41 Whereas hyperphosphorylation of H2A.X in apoptotic cells depends indirectly on activation of caspases and nuclear scaffold (lamin) proteases, as shown in zVAD-(OMe)-fmk or zAPF-cmktreated cells, H1 dephosphorylation can be inhibited only by the caspase inhibitors zVAD-(OMe)-fmk and Ac-YVADcmk and not by the used nuclear scaffold protease inhibitor.
Materials and Methods
Cell culture and induction of apoptosis NIH 3T3 fibroblasts were grown in monolayer cultures and cultivated in DMEM (Gibco LTD, Paisley, Scotland) supplemented with 10% fetal calf serum, penicillin (60 mg/ml) and streptomycin (100 mg/ml) in the presence of 5% CO 2 . To induce apoptotic cell death cells were incubated with 100 ng/ml murine TNFa (Alexis Corporation, San Diego, USA) or 100 ng/ml anti-Fas antibody (JO2) (PharMingen, San Diego, USA) in combination with 2.5 mg/ml cycloheximide.
Protein kinase inhibitors and activators and proteinase inhibitors
We used H89 as protein kinase A and G inhibitor (2 mM), staurosporine as protein kinase C inhibitor (10 nM), phorbol 12-myristate 13-acetate as protein kinase C activator (150 nM), PD98059 as MEK (MAP) kinase inhibitor (10 mM), calyculin A as MAP kinase activator and phosphatase 1 and 2A inhibitor (10 nM), genistein as tyrosin protein kinase inhibitor (100 mM), and Wortmannin as DNA protein kinase inhibitor (5 mM and 150 mM). 3-aminobenzamide (1 mM) was used as poly(ADP-ribose) polymerase (PARP) inhibitor. Serine proteinase inhibitor Tos-Phe-chloromethylketone (TPCK) (50 mM), nuclear scaffold proteinase inhibitor Z-Ala-Pro-Phe-chloromethylketone (zAPF-cmk) (50 mM) or caspase inhibitors Ac-Tyr-Val-Ala-Asp-chloromethylketone (Ac-YVAD-cmk) (100 mM), Z-Asp-Glu-Val-Asp-chloromethylketone (zDEVD-cmk) (200 mM) and Z-Val-Ala-Asp(OMe)-fluoromethylketone (zVAD-(OMe)-fmk) (100 mM) were used for apoptosis inhibition. zAPF-cmk and the caspase inhibitors were from Bachem, Bubendorf, Switzerland. All other used substances were from Alexis Corporation, San Diego, USA.
Detection of apoptotic cells
Cell monolayers were incubated with TNF-a in the presence of cycloheximide, or left untreated as controls. Cells were harvested and resuspended in phosphate buffered normal saline (pH 7.4). One hundred microliters of cell suspension was fixed with 100 ml of 3% paraformaldehyde for 5 min at 48C, washed with distilled water, dropped (10 ml) onto a slide and dried at room temperature. For inspection of chromatin, cells were stained with 8 mg/ml of Hoechst 33258. For electron microscopy the monolayers were For the examination of DNA fragmentation cells treated with apoptosis inducer were lysed in 0.5 ml of a buffer containing 5 mM Tris, pH 8.0, 20 mM EDTA, and 0.5% (w/v) Triton X-100. After incubation for 15 min at 48C, samples were centrifuged for 20 min at 15 0006g to remove debris. The supernatant fraction containing fragmented DNA was digested with proteinase K (200 mg/ml) at 378C for 3 h and then extracted once with an equal volume phenol followed by extraction with chloroform/ isoamylalcohol (25/1). DNA was precipitated with 0.3 M sodium acetate and three volumes of ethanol at 7708C overnight. After centrifugation (25 0006g) the precipitated DNA was washed with 95% ethanol and resuspended in a buffer containing 10 mM Tris, pH 8.0, 1 mM EDTA, and 50 mg/ml RNase A. After incubation at 378C for 60 min, DNA was analyzed by 2% agarose gel electrophoresis.
Labeling conditions and isolation of H1 and core histones
For time course experiments NIH cells were labeled for 60 min in sodium phosphate-deficient DMEM with carrier-free [ 32 P]orthophosphate (1.2 mCi/2610 7 cells per time point, 30 mCi/ml medium; NEN) during the various time points of treatment with TNFa. For all other experiments the cultures were incubated for 4 h. Thereafter, the labeling was stopped by washing with ice-cold PBS containing 50 mM NaHSO 3 . For isolation of histones, nuclei from NIH fibroblasts were prepared as described. 13 H1 histones were isolated from the resulting nuclear preparations by extracting with 5% perchloric acid at 48C for 1 h. The mixture was centrifuged at 10 0006g for 20 min. The remaining pellet was resuspended with 0.4 M H 2 SO 4 at 48C for 1 h to extract the core histones. Thereafter, the mixture was centrifuged at 10 0006g for 20 min. The H1 and core histones containing supernatants were mixed with trichloroacetic acid to the final concentration of 20% and allowed to stand for 1 h at 48C. The precipitates were washed once with acetone-HCl and thereafter with acetone, resuspended in water containing 10 mM 2-mercaptoethanol, and freeze-dried.
RP-HPLC
The equipment used consisted of a 127 Solvent Module and a Model 166 u.v.-visible-region detector (Beckman Instruments, Palo Alto, CA, USA). The effluent was monitored at 210nm and the peaks were recorded using a Beckman System Gold software. Histone H1 separation was performed on a Nucleosil 300-5 C4 column (12.5 cm or 25 cm60.8 cm, 5 m beads, 300 A Ê ). The freezedried proteins were dissolved in 0.04 M 2-mercaptoethanol/water containing 0.1% TFA, and samples of 100 mg to 300 mg histones were loaded onto the column. At a constant flow rate of 1 ml/min and 1.5 ml/min the H1 histones were eluted using a 45-min linear gradient from 34 ± 54% B (solvent A: water containing 15% ethylene glycolmonomethylether and 0.1% TFA, solvent B: ethylene glycolmonomethylether (15%)/70% acetonitrile (85%) with 0.1% TFA). 42 ± 44 Core histone separation was performed on a Ultrapore TM C 3 column (25 cm61 cm I.D.; 5 mm particle pore size; 300 A Ê ; endcapped; Beckman Instruments, Palo Alto, CA, USA). The lyophilized proteins were dissolved in 0.04 mM 2-mercaptoethanol/water containing 0.1% TFA, and samples of 500 mg were injected onto the column. At a constant flow of 1.5 ml/min the core histones were eluted using a two-step acetonitrile gradient starting at solvent A ± solvent B (54 : 46) (solvent A: water containing 0.1% TFA; solvent B: 70% acetonitrile and 0.1% TFA). The concentration of solvent B was increased from 46% to 56% B during 45 min and from 56% to 100% B during 20 min. The protein fractions were collected and after adding 50 ml 2-mercaptoethanol (0.2 M) lyophilized and stored at 7208C.
The peptides obtained by digestion of histone H2A.X with Endoproteinase Glu-C were separated using a Nucleosil 300-5 C 18 column (150 mm62 mm I.D.; 5 mm particle pore size; end-capped; Macherey-Nagel, Du È ren, Germany). Samples of *5 mg were injected onto the column. Chromatography was performed within 75 min at a constant flow of 0.3 ml/min with a two-step acetonitrile gradient starting at solvent A ± solvent B (85 : 15) (solvent A: water containing 0.1% TFA; solvent B: 85% acetonitrile and 0.1% TFA). The concentration of solvent B was increased linearly from 15% to 60% during 60 min and from 60% to 100% during 15 min. Peptide fragments obtained in this way were analyzed by Edman degradation and ESI-MS.
Endoproteinase Glu-C digestion Histone H2A.X (*5 mg) obtained by RP-HPLC fractionation was digested with Endoproteinase Glu-C from Staphylococcus aureus V8 (1/20 w/w) in 25 mM ammonium acetate buffer (pH 4.0) for 2 h at room temperature.
Gel electrophoresis and autoradiography
Histones were resolved both on SDS-18% polyacrylamide gel 45 and on 24-cm or 32-cm long Triton acid-urea-15% polyacrylamide gels (15% acrylamide, 0.125% bisacrylamide, 8 M urea, 6 mM Triton X-100, 5% acetic acid). 46, 47 Gels were prerun for 6 h with a top layer of 1 mM cysteamine. Electrophoresis was carried out in 5% acetic acid, 0.1% (v/v) Triton X-100 with an applied constant current of 12 mA in a buffer-cooled electrophoresis tank for 18 h. Gels subsequently were fixed and stained with 0.1% Coomassie blue R 250. After staining and drying gels were quantified to estimate the protein quantities by using Hirschmann scanning densitometer and the Elscript 440 software. The radioactivity incorporated into each band was quantified by using Molecular Dynamics Phosphorlmager and the ImageQuant software. The specific activity of each band was determined from the densitometric and Phosphorlmager analysis.
